Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Impact of Chronic Disease and Its Burden on Aspects of Quality of Life in a Unique Sub-Population of Myeloproliferative Neoplasm Patients

Peter Loffelhardt, Ryan Eckert, Judit Diaz Campos, Ruben Mesa, Carles Besses Raebel

Blood (2022) 140 (Supplement 1): 3978–3979.

https://doi.org/10.1182/blood-2022-162714

Published: 2022

Journal Articles

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Nieves Garcia-Gisbert, Brayan Merchan, Sara Garcia-Avila, Marta Salido, Concepción Fernández-Rodríguez, Joan Gibert, Lierni Fernández-Ibarrondo, Laura Camacho, Marta Lafuente, Raquel Longarón, Blanca Espinet, Patricia Vélez, Marcio M Andrade-Campos, Ramon M. Pujol, Leonor Arenillas, Xavier Calvo, Carles Besses, Antonio Salar, Beatriz Bellosillo

Blood (2021) 138 (Supplement 1): 2599.

https://doi.org/10.1182/blood-2021-148297

Published: 2021

Journal Articles

Clonal Dynamics of JAK2 V617F and Non-Driver Mutations in Polycythemia Vera and Essential Thrombocythemia Patients Receiving Hydroxyurea Therapy

Lierni Fernández-Ibarrondo, Joan Gibert, Concepción Fernández-Rodríguez, Laura Camacho, Anna Angona, Marcio Andrade, Nieves Garcia-Gisbert, Leonor Arenillas, Patricia Vélez, Raquel Longarón, Ramon Diez-Feijoo, Antonio Salar, Carles Besses, Beatriz Bellosillo

Blood (2021) 138 (Supplement 1): 3623.

https://doi.org/10.1182/blood-2021-150491

Published: 2021

Journal Articles

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Marcio M Andrade-Campos, MD PhD, Lierni Fernández-Ibarrondo, Joan Gibert, PhD, Concepción Fernández, Brayan Merchan, MD, Nieves García Gisbert, BSc, Laura Camacho, Leonor Arenillas, MD PhD, Sara García Ávila, MD, Raquel Longarón, Antonio Salar, MD PhD, Carles Besses, MD PhD, Beatriz Bellosillo, PhD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-142705

Published: 2020

Journal Articles

Molecular Characterization of Ph-Negative Myeloproliferative Neoplasms in Tumor Circulating Nucleic Acids

Nieves Garcia-Gisbert, MSc, Lierni Fernández-Ibarrondo, Concepción Fernández-Rodríguez, Laura Camacho, Anna Angona, MD PhD, Joan Gibert, PhD, Xavier Calvo, MD PhD, Leonor Arenillas, MD PhD, Raquel Longarón, Marcio Andrade, MD PhD, Antonio Salar, MD PhD, Carles Besses, MD PhD, Beatriz Bellosillo, PhD

Blood (2019) 134 (Supplement_1): 2953.

https://doi.org/10.1182/blood-2019-123003

Published: 2019

Journal Articles

Long-Term Efficacy and Safety (5 Years) in RESPONSE, a Phase 3 Study Comparing Ruxolitinib (rux) with Best Available Therapy (BAT) in Hydroxyurea (HU)-Resistant/Intolerant Patients (pts) with Polycythemia Vera (PV)

Blood (2018) 132 (Supplement 1): 1753.

https://doi.org/10.1182/blood-2018-99-115129

Published: 2018

Journal Articles

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Blood (2018) 132 (Supplement 1): 3072.

https://doi.org/10.1182/blood-2018-99-119221

Published: 2018

Journal Articles

Genetic Predisposition to Molecular Response in Patients with Myeloproliferative Neoplasms Treated with Hydroxycarbamide

Anna Angona, Beatriz Bellosillo, Alberto Alvarez-Larrán, Luz Maria Martinez-Aviles, Laura Camacho, Silvia Pairet, Concepción Fernández, Carles Besses

Blood (2012) 120 (21): 1738.

https://doi.org/10.1182/blood.V120.21.1738.1738

Published: 2012

Journal Articles

A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera

Juan-Carlos Hernández-Boluda, Arturo Pereira, Francisco Cervantes, Alberto Alvarez-Larrán, María Collado, Esperanza Such, M. Jesús Arilla, Concepción Boqué, Blanca Xicoy, Margherita Maffioli, Beatriz Bellosillo, Isabel Marugán, Paula Amat, Carles Besses, Vicent Guillem

Blood (2012) 119 (22): 5221–5228.

https://doi.org/10.1182/blood-2012-02-411215

Published: 2012

Includes: Supplemental data

Journal Articles

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Alberto Alvarez-Larrán, Arturo Pereira, Francisco Cervantes, Eduardo Arellano-Rodrigo, Juan-Carlos Hernández-Boluda, Francisca Ferrer-Marín, Anna Angona, Montse Gómez, Begoña Muiña, Helga Guillén, Anabel Teruel, Beatriz Bellosillo, Carmen Burgaleta, Vicente Vicente, Carles Besses

Blood (2012) 119 (6): 1363–1369.

https://doi.org/10.1182/blood-2011-10-387787

Published: 2012

Journal Articles

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

Blood (2011) 117 (10): 2813–2816.

https://doi.org/10.1182/blood-2010-11-316810

Published: 2011

Includes: Supplemental data

Journal Articles

Clinical Evaluation of the European LeukemiaNet Criteria for Resistance/Intolerance to Hydroxyurea In Essential Thrombocythemia

Carles Besses, Alberto Alvarez-Larrán, Montserrat Gómez, Anna Angona, Paula Amat, Beatriz Bellosillo, Luz Martínez-Avilés, Blanca Navarro, Ana Isabel Teruel, Francisco Martínez-Ruiz, Juan Carlos Hernández-Boluda

Blood (2010) 116 (21): 4086.

https://doi.org/10.1182/blood.V116.21.4086.4086

Published: 2010

Journal Articles

Absence of Mutations of the Histone Methyltransferase Gene EZH2 In Splenic B-Cell Marginal Zone Lymphoma

Luz Martínez-Avilés, Marta Salido, Beatriz Bellosillo, Vera Adema, Ana Ferrer, Antonio Salar, Dr., Mar Garcia, Blanca Espinet, Lourdes Florensa, Carles Besses, Sergi Serrano, Francesc Sole

Blood (2010) 116 (21): 5086.

https://doi.org/10.1182/blood.V116.21.5086.5086

Published: 2010

Journal Articles

LY2784544, a Novel JAK2 Inhibitor, Decreases In Vitro Growth of Hematopoietic Human Progenitors From JAK2 V617F Positive Polycythemia Vera Patients

Lourdes Florensa, Beatriz Bellosillo, Leonor Arenillas, Liandong Ma, Ph., D, Richard Walgren, MD, PhD, Alberto Alvarez, Judit Gonzalez, Rosa M Vila, Raquel Longarón, Carles Besses

Blood (2010) 116 (21): 5054.

https://doi.org/10.1182/blood.V116.21.5054.5054

Published: 2010

Journal Articles

Modified-CHOP with Reduced Dose of Non-Pegylated Liposomal Doxorubicin ± Rituximab in First Line Treatment for Elderly Patients with Aggressive Lymphoma Non Suitables for Standard Chemotherapy.

Eva Gimeno, Blanca Sánchez, Alberto Alvarez, Carme Pedro, Eugenia Abella, Miquel Gomez, Silvia Saumell, Josep Comin, Carles Besses, Antonio Salar

Blood (2009) 114 (22): 4752.

https://doi.org/10.1182/blood.V114.22.4752.4752

Published: 2009

Journal Articles

Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: a European Multicenter Study.

Francesco Passamonti, Susanne Schnittger, François Girodon, Jean-Jacques Kiladjian, Mary Frances McMullin, Marco Ruggeri, Eric Lippert, Alessandro Vannucchi, Carles Besses, Elisa Rumi, Chiara Elena, Torsten Haferlach, Cristiana Pascutto, Mario Cazzola

Blood (2009) 114 (22): 3904.

https://doi.org/10.1182/blood.V114.22.3904.3904

Published: 2009

Journal Articles

Does PDG-PET Add Additional Prognostic Information to CT Staging in Lymphoma Patients?

Blanca Sanchez-Gonzalez, MD, PhD, Carlos Trampal, MD, Alberto Solano, MD, Carmen Pedro, MD, Jm Maiques, MD, Alberto Alvarez, MD, PhD, Eva Gimeno, MD, Eugenia Abella, MD, PD, Carles Besses, MD, PhD, Antonio Salar, MD, PhD

Blood (2008) 112 (11): 4949.

https://doi.org/10.1182/blood.V112.11.4949.4949

Published: 2008

Journal Articles

Gene Expression Profiling Distinguishes Essential Thrombocythemia from Polycythemia Vera Patients and Identifies a Common Expressed Set of Genes in Relation to JAK2V 617F Status

Eulalia Puigdecanet, Blanca Espinet, PhD, Juan Jose Lozano, PhD, Lauro Sumoy, PhD, Beatriz Bellosillo, PhD, Miquel Granell, MD, Alberto Alvarez-Larrán, MD, PhD, Leonor Arenillas, MD, Francesc Sole, PhD, Sergi Serrano, MD, PhD, Francisco Cervantes, MD, PhD, Carles Besses, MD, PhD, Lourdes Florensa, MD, PhD

Blood (2008) 112 (11): 2788.

https://doi.org/10.1182/blood.V112.11.2788.2788

Published: 2008

Journal Articles

Reduced Dose of Non-Pegylated Liposomal Doxorrubicin with Cyclophosphamide, Vincristine and Prednisone ± Rituximab for Elderly Patients with Aggressive Lymphoma Non Candidates to Standard Chemotherapy.

Eva Gimeno, Alberto Alvarez, Carme Pedro, Eugenia Abella, Miquel Gomez, Josep Comin, Carles Besses, Antonio Salar

Blood (2007) 110 (11): 4464.

https://doi.org/10.1182/blood.V110.11.4464.4464

Published: 2007

Journal Articles

Analysis of JAK2V617F Mutation, PRV-1 Overexpression and Endogenous Erythroid Colony (EEC) Formation Show Different Coexpression Patterns among Ph-Negative Chronic Myeloproliferative Disorders.

Beatriz Bellosillo, PhD, Carles Besses, MD, PhD, Lourdes Florensa, MD, PhD, Raquel Longaron, Gemma Navarro, Eva Gimeno, MD, Francesc Sole, PhD, Rosa M. Vila, Sergi Serrano, MD, PhD

Blood (2005) 106 (11): 2592.

https://doi.org/10.1182/blood.V106.11.2592.2592

Published: 2005

NARROW

Impact of Chronic Disease and Its Burden on Aspects of Quality of Life in a Unique Sub-Population of Myeloproliferative Neoplasm Patients

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Clonal Dynamics of JAK2 V617F and Non-Driver Mutations in Polycythemia Vera and Essential Thrombocythemia Patients Receiving Hydroxyurea Therapy

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Molecular Characterization of Ph-Negative Myeloproliferative Neoplasms in Tumor Circulating Nucleic Acids

Long-Term Efficacy and Safety (5 Years) in RESPONSE, a Phase 3 Study Comparing Ruxolitinib (rux) with Best Available Therapy (BAT) in Hydroxyurea (HU)-Resistant/Intolerant Patients (pts) with Polycythemia Vera (PV)

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Genetic Predisposition to Molecular Response in Patients with Myeloproliferative Neoplasms Treated with Hydroxycarbamide

A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

Clinical Evaluation of the European LeukemiaNet Criteria for Resistance/Intolerance to Hydroxyurea In Essential Thrombocythemia

Absence of Mutations of the Histone Methyltransferase Gene EZH2 In Splenic B-Cell Marginal Zone Lymphoma

LY2784544, a Novel JAK2 Inhibitor, Decreases In Vitro Growth of Hematopoietic Human Progenitors From JAK2 V617F Positive Polycythemia Vera Patients

Modified-CHOP with Reduced Dose of Non-Pegylated Liposomal Doxorubicin ± Rituximab in First Line Treatment for Elderly Patients with Aggressive Lymphoma Non Suitables for Standard Chemotherapy.

Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: a European Multicenter Study.

Does PDG-PET Add Additional Prognostic Information to CT Staging in Lymphoma Patients?

Gene Expression Profiling Distinguishes Essential Thrombocythemia from Polycythemia Vera Patients and Identifies a Common Expressed Set of Genes in Relation to JAK2V 617F Status

Reduced Dose of Non-Pegylated Liposomal Doxorrubicin with Cyclophosphamide, Vincristine and Prednisone ± Rituximab for Elderly Patients with Aggressive Lymphoma Non Candidates to Standard Chemotherapy.

Analysis of JAK2V617F Mutation, PRV-1 Overexpression and Endogenous Erythroid Colony (EEC) Formation Show Different Coexpression Patterns among Ph-Negative Chronic Myeloproliferative Disorders.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only